Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients

• Autorzy: Nadaj-Pakleza A. , Lusakowska A. , Sulek-Piatkowska A. , Krysa W. , Rajkiewicz M. , Kwiecinski H. , Kaminska A.
• Języki publikacji: EN

Abstrakty

EN

Myotonic dystrophy (DM) is the most common muscular dystrophy in adults. Two known genetic subtypes include DM1 (myotonic dystrophy type 1) and DM2 (myotonic dystrophy type 2). Genetic testing is considered as the only reliable diagnostic criterion in myotonic dystrophies. Relatively little is known about DM1 and DM2 myopathology. Thus, the aim of our study was to characterise light and electron microscopic features of DM1 and DM2 in patients with genetically proven types of the disease. We studied 3 DM1 cases and 15 DM2 cases from which muscle biopsies were taken for diagnostic purposes during the period from 1973 to 2006, before genetic testing became available at our hospital. The DM1 group included 3 males (age at biopsy 15–19). The DM2 group included 15 patients (5 men and 10 women, age at biopsy 26–60). The preferential type 1 fibre atrophy was seen in all three DM1 cases in light microscopy, and substantial central nucleation was present in two biopsies. Electron microscopy revealed central nuclei in all three examined muscle biopsies. No other structural or degenerative changes were detected, probably due to the young age of our patients. Central nucleation, prevalence of type 2 muscle fibres, and the presence of pyknotic nuclear clumps were observed in DM2 patients in light microscopy. Among the ultrastructural abnormalities observed in our DM2 group, the presence of internal nuclei, severely atrophied muscle fibres, and lipofuscin accumulation were consistent findings. In addition, a variety of ultrastructural abnormalities were identified by us in DM2. It appears that no single ultrastructural abnormality is characteristic for the DM2 muscle pathology. It seems, however, that certain constellations of morphological changes might be indicative of certain types of myotonic dystrophy. (Folia Morphol 2011; 70, 2: 121–129)

• Wydawca: -
• Czasopismo: Folia Morphologica
• Rocznik: 2011
• Tom: 70
• Numer: 2
• Opis fizyczny: p.121-129,fig.,ref.

Twórcy

autor

Nadaj-Pakleza A.

• Department of Neurology, Medical University of Warsaw, Poland
• Service de Neurologie, Centre de Reference des Maladies Neuromusculaires, Nantes Angers, France
• Centre de Reference des Maladies Neuromusculaires, Service de Neurology, Centre Hospitalier Universitaire d'Angers, 4rue Larrey, 49933 Angers, France

autor

Lusakowska A.

• Department of Neurology, Medical University of Warsaw, Poland

autor

Sulek-Piatkowska A.

• Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland

autor

Krysa W.

• Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland

autor

Rajkiewicz M.

• Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland

autor

Kwiecinski H.

• Department of Neurology, Medical University of Warsaw, Poland

autor

Kaminska A.

• Department of Neurology, Medical University of Warsaw, Poland
• Neuromuscular Unit, Mossakowski Medical Centre, Polish Academy of Sciences, Warsaw, Poland

Bibliografia

• 1. Bassez G, Chapoy E, Bastuji-Garin S, Radvanyi-Hoffman H, Authier F-J, Pellissier JF, Eymard B, Gherardi RK (2008) Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy. J Neuropathol Exp Neurol, 4: 319–325.
• 2. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3’end of a transcript encoding a protein kinase family member. Cell, 69: 385.
• 3. Brooke MH, Engel WK (1969) The histographic analysis of human muscle biopsies with regard to fiber types. 2. Myotonias, myasthenia gravis and hypokaliemic periodic paralysis. Neurology, 19: 469–477.
• 4. Brooke MH, Engel WK (1969) The histographic analysis of human muscle biopsies with regard to fiber types. 2. Diseases of upper and lower motor neuron. Neurology, 19: 378–393.
• 5. Carpenter S, Karpati G eds. (2001) Pathology of skeletal muscle. Oxford University Press.
• 6. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LPW (2003) Myotonic dystrophy type 2. Molecular, diagnostic and clinical spectrum. Neurology, 60: 657–664.
• 7. Day JW, Ranum LP (2005) RNA pathogenesis of the myotonic dystrophies. Neuromuscular Disord, 15: 5–16.
• 8. Dubowitz V ed. (1985) Muscle biopsy. A practical approach. Bailliere Tindall, London, Philadelphia, Toronto.
• 9. Dubowitz V, Sewry CA eds. (2007) Muscle biopsy. A practical approach. Elsevier, Philadelphia.
• 10. Engel AG, Banquer BQ eds. (1986) Myology. Mc Graw Hill, New York.
• 11. Engel AG, Stonnington HH (1974) Morphological effects of denervation on muscle. A quantitative ultrastructural study. Ann NY Acad Sci, 228: 68–88.
• 12. Engel WK, Brooke MH (1966) The histologic diagnosis of neuromuscular diseases: review of 79 biopsies. Arch Phys Med Rehabil, 47: 99–121.
• 13. Furling D, Doucet G, Langlois MA, Timchenko L, Belanger E, Cossette L, Puymirat J (2003) Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy. Am J Pathol, 162: 1001–1009.
• 14. Harper PS (2001) Myotonic dystrophy. 3rd Ed. WB Saunders, London.

Uwagi

rekord w opracowaniu